Riskpilot← Back to searchSign inGet full accessNB Vård och Tandvård AB
ABActiveOrg 5592447865Karlbergsvägen 14 1trDental practice care activities · NACE 8623Est. 20201 employees
Revenue 2024
SEK 2,5M
+3% vs 2023
EBITDA margin
33.7%
+390% vs 2023
Equity ratio
76.6%
Financial strength
Net profit 2024
SEK 333K
+43% vs 2023
| Revenue | SEK 2,5M | +3% |
| EBITDA | SEK 857K | +390% |
| Net profit | SEK 333K | +43% |
| Total assets | SEK 1,7M | +30% |
| Equity | SEK 1,3M | +34% |
| Employees | 1 | — |
Legal name
NB Vård och Tandvård AB
Org number
5592447865
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
27 februari 2020
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandläkarmottagning med estetiska injektionsbehandlingar därmed förenlig verksamhet.
Address
Karlbergsvägen 14 1tr
Email
nbvtab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 044 | 3 729 | 2 468 | 2 541 |
| Staff expenses | — | −28 | −991 | −703 |
| EBITDA | 298 | 1 791 | 175 | 857 |
| Depreciation & amort. | −229 | −474 | −380 | −416 |
| EBIT | 69 | 1 316 | −205 | 441 |
| Net financials | −26 | −40 | −28 | −20 |
| Profit before tax | 43 | 836 | 297 | 422 |
| Tax | −10 | −173 | −64 | −88 |
| Net profit | 33 | 663 | 233 | 333 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 765 | 1 501 | 1 316 | 1 713 |
| Equity | 83 | 746 | 979 | 1 312 |
| Long-term debt | 638 | 413 | 263 | 113 |
| Short-term debt | 45 | 63 | 75 | 289 |
| Total debt | 683 | 475 | 337 | 402 |
EBITDA margin
33.7%
This company
15.8%
Market median
+113% vs market
20212024
Equity ratio
76.6%
This company
38.2%
Market median
+101% vs market
20212024
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
20212024
Net profit margin
13.1%
This company
8.1%
Market median
+62% vs market
20212024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20212024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JN Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nooris vård och tandvård AB
NB Vård och Tandvård AB Board members of NB Vård och Tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josef Noori | Chief Executive Officer | 0 companies |
| Adam Aos Beldin | Board of Directors | 0 companies |
| Jonas Genc | Deputy Board Member | 0 companies |
| Mercedez Genc | Board of Directors | 0 companies |
| Noor Hazim | Deputy Board Member | 0 companies |